Message from the CEO
Twenty-five years ago, SMT was founded with a deep sense of purpose: to make life-saving medical devices accessible. We have always believed that patients come first and every decision at SMT is shaped by this core philosophy.
Since our inception, we have aimed to save millions of lives by delivering innovative medical devices to as many people as possible. Over the last two decades, our R&D capabilities have grown significantly deepening our understanding of cardiovascular science and advanced technologies. This has enabled us to build a pipeline of innovative solutions. Our expertise has led to the development of pioneering biodegradable polymer and most deliverable stents, widely recognized by leading cardiologists and experts as among the most effective solutions for complex PCI cases.
Today, SMT is proud to offer a robust portfolio of solutions in Vascular and Structural Heart Interventions. Our belief in evidence-based medicine has driven investment in global clinical trials, with a continued commitment to validate our products and future therapies through data.
We are also proud to have earned brand equity, supported by the endorsements of key opinion leaders around the world who trust the safety and efficacy of SMT products. Their confidence inspires us to push boundaries with purposeful and precise innovation.
SMT is deeply committed to Environmental, Social, and Governance (ESG) excellence. Our corporate governance structure ensures institutionalized systems and processes anchored in transparency and global best practices.
Looking ahead, we aim to build on our rich legacy by applying our scientific knowledge and technological capabilities to address broader cardiovascular needs and reinforcing SMT’s position as a trusted name in cardiovascular devices industry.
At SMT, we are not just building products, we are building hope, impact, and a future where millions more lives can be saved.
